Boon Industries, Inc. (BNOW)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Boon Industries, Inc. (BNOW) with AI Score 45/100 (Grade C). Boon Industries, Inc. (BNOW) is a bioscience firm engineering chemical products for agriculture, food and beverages, hospitality, and healthcare sectors. Sector: Basic materials.
Last analyzed: Jun 14, 2026BNOW: the 1 perspectives are evenly split.
How is this calculated? →Boon Industries, Inc. (BNOW) Materials & Commodity Exposure
Boon Industries, Inc. (BNOW) is a bioscience firm specializing in chemical products for agriculture, food and beverages, hospitality, and healthcare. Its offerings include DiOx+, an activated chlorine dioxide disinfectant, white-label nutritional supplements using nano-emulsification, and reconfigured shipping containers for agricultural use, serving domestic and global markets from Grass Valley, California.
What Is the Investment Thesis for BNOW?
Boon Industries, Inc. (BNOW) presents an investment profile centered on its specialized bioscience products targeting essential sectors. The company's flagship DiOx+ activated chlorine dioxide formula addresses critical needs in disinfection and sterilization across healthcare, hospitality, and food industries, offering a potent solution against pathogens. This product's dual benefit of efficacy and environmental safety positions it favorably in a growing market for advanced hygiene solutions. Additionally, Boon Industries leverages nano-emulsification technology for its white-label nutritional supplements, tapping into the expanding health and wellness market with differentiated products. With a gross margin of 63.7%, the company demonstrates strong product-level profitability, suggesting efficient cost management in its core offerings. The reconfigured shipping containers for agriculture further diversify its revenue streams into a sector with ongoing infrastructure demands. However, the company's market capitalization of $0.07 billion and a significant negative profit margin of -15535.5% indicate a micro-cap entity facing substantial operational challenges and a need for improved financial performance. Its high beta of 2.44 suggests considerable price volatility. The investment thesis hinges on the potential for its specialized products to gain market traction and scale, thereby improving profitability and mitigating the risks associated with its current financial metrics and OTC Other listing.
Based on FMP financials and quantitative analysis
BNOW Key Highlights
- Market Capitalization: $0.07 billion, indicating Boon Industries, Inc. operates as a micro-cap company within the Basic Materials sector.
- Gross Margin: 63.7%, demonstrating strong profitability at the product level, suggesting efficient cost of goods sold for its specialized chemical products.
- Profit Margin: -15535.5%, highlighting significant operational losses relative to revenue, which points to substantial overhead or development costs.
- Beta: 2.44, indicating that BNOW's stock price exhibits significantly higher volatility compared to the overall market, suggesting increased risk.
- Employee Count: 2 employees, reflecting a highly lean operational structure, potentially relying on outsourcing or specialized contract work for its diverse product lines.
Who Are BNOW's Competitors?
BNOW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ASPI ASP Isotopes Inc. | $5.53 | -1.78% | $459.53M | 60 |
| CNSJF China Sanjiang Fine Chemicals Company Limited | $0.16 | +0.00% | $187.57M | 57 |
| UNVR Univar Solutions Inc. | $36.14 | +0.47% | $5.70B | 54 |
| ORGN Origin Materials, Inc. | $0.95 | -0.00% | $5.23M | 52 |
| KOYJF Kemira Oyj | $19.60 | +4.37% | $2.90B | 45 |
| INDOY Indorama Ventures Public Company Limited | $7.03 | +0.00% | $3.95B | 45 |
| BLGO BioLargo, Inc. | $0.11 | -0.45% | $35.30M | 46 |
| AHKSF Asahi Kasei Corporation | $11.20 | -0.88% | $15.19B | 46 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BNOW's Key Strengths?
- Diverse product portfolio catering to critical sectors (DiOx+, nutritional supplements, agricultural containers).
- Proprietary DiOx+ formula offers effective and environmentally safe disinfection.
- Utilizes advanced nano-emulsification technology for enhanced nutritional supplement products.
- Strong gross margin of 63.7% indicates efficient product-level cost management.
What Are BNOW's Weaknesses?
- Significant negative profit margin (-15535.5%) indicates substantial operational losses.
- Very small employee base (2 employees) may limit scalability and operational capacity.
- OTC Other listing implies less stringent reporting and potential transparency issues.
- High beta (2.44) suggests considerable stock price volatility and increased investment risk.
What Could Drive BNOW Stock Higher?
- **New Product Development or Application Expansion**: The introduction of new bioscience-engineered products or the successful expansion of DiOx+'s applications into new high-demand sectors could drive revenue growth.
- **Strategic Partnerships or Distribution Agreements**: Securing significant white-label contracts for nutritional supplements or establishing new distribution channels for DiOx+ could accelerate market penetration and sales.
- **Increased Demand for Disinfection Solutions**: Continued global focus on hygiene and pathogen control, particularly in healthcare and food safety, could drive sustained demand for DiOx+.
- **Improved Financial Reporting and Transparency**: Any move towards more consistent and public financial disclosures, or an upgrade to a higher OTC tier, could enhance investor confidence and liquidity.
- **Expansion of Agricultural Container Business**: Securing large-scale contracts for reconfigured shipping containers with major agricultural clients could significantly boost this segment's revenue.
What Are the Key Risks for BNOW?
- Financial-distress signal — its Altman Z-Score of -11.88 sits in the distress zone (elevated bankruptcy risk).
- **Significant Operational Losses**: The current profit margin of -15535.5% indicates substantial ongoing operational losses, posing a risk to long-term financial viability if not addressed.
- **Limited Transparency and Liquidity**: As an 'OTC Other' listed stock with 'Unknown' disclosure status, investors face risks related to limited information, low trading volume, and difficulty in executing trades.
- **Intense Competition**: Operating in the chemicals and bioscience sectors, Boon Industries faces competition from larger, well-capitalized companies with greater R&D and marketing resources.
- **Reliance on Key Personnel**: With only two employees, the company's operations and strategic direction may be heavily reliant on a very small team, posing a continuity risk.
- **Regulatory Compliance Challenges**: The chemical and food supplement industries are subject to stringent regulations; any non-compliance could lead to significant penalties or operational disruptions.
What Are the Growth Opportunities for BNOW?
- Growth opportunity 1: **Expansion of DiOx+ Market Penetration**: The DiOx+ activated chlorine dioxide formula, designed as a potent disinfectant and sterilizer, holds significant growth potential. The global market for disinfectants and sanitizers is expanding, driven by heightened hygiene awareness in healthcare, food processing, and public spaces. By targeting new applications within these sectors or expanding its geographic reach, Boon Industries could significantly increase sales. The product's safety profile for individuals and the environment provides a competitive edge in a market increasingly valuing sustainable and non-toxic solutions. Strategic partnerships or certifications could further accelerate adoption and market share capture, potentially tapping into a multi-billion dollar market over the next 3-5 years.
- Growth opportunity 2: **Leveraging Nano-Emulsification in Nutritional Supplements**: Boon Industries' expertise in manufacturing white-label liquid nutritional supplement tinctures using nano-emulsification technology presents a substantial growth avenue. The global nutritional supplements market, particularly for advanced delivery systems that enhance bioavailability, is experiencing robust growth. Nano-emulsification allows for improved absorption and stability of active ingredients, making these products highly attractive to health-conscious consumers and supplement brands. Expanding its client base for white-label manufacturing and potentially developing its own branded products could unlock significant revenue streams. This market segment is projected to grow consistently over the next decade, offering a long-term opportunity for specialized providers.
- Growth opportunity 3: **Diversification and Customization of Agricultural Container Solutions**: The company's offering of reconfigured shipping containers tailored for agricultural applications addresses a niche but growing demand for innovative and adaptable farming infrastructure. As agriculture evolves towards more controlled environments, urban farming, and efficient resource utilization, specialized container solutions become increasingly relevant. Growth can be achieved by expanding the range of container configurations, developing smart farming integrations, or targeting new agricultural sub-sectors like aquaculture or vertical farming. The market for agricultural technology and infrastructure is experiencing significant investment, presenting opportunities for Boon Industries to scale its specialized container business over the medium term (3-7 years).
- Growth opportunity 4: **Geographic Expansion into Underserved Markets**: Boon Industries currently serves both domestic and global markets, indicating an existing infrastructure for international operations. A focused strategy to penetrate specific underserved or rapidly growing international markets for its DiOx+ disinfectant or nano-emulsified supplements could be a significant growth driver. Many developing economies are increasing their standards for hygiene and food safety, creating substantial demand for effective disinfectants. Similarly, the global demand for health supplements is rising. Identifying key regions with high growth potential and establishing targeted distribution channels could unlock new revenue streams over the next 5-10 years, amplifying its global footprint.
- Growth opportunity 5: **Research and Development of New Bioscience Products**: As a bioscience firm, continuous innovation through research and development is a core growth opportunity. Investing in R&D to develop new chemical products or enhance existing ones, particularly those addressing emerging market needs or offering superior performance, could secure future market leadership. This could involve exploring new applications for chlorine dioxide, developing novel nano-emulsified ingredients, or venturing into entirely new bioscience-related solutions for its target sectors. Successful product innovation could lead to new patents, expanded market share, and increased profitability, positioning the company for long-term sustainable growth within the dynamic basic materials and chemicals industry.
What Opportunities Does BNOW Have?
- Expanding demand for advanced disinfectants in healthcare and food safety sectors globally.
- Growth in the white-label nutritional supplement market, especially with innovative delivery technologies.
- Increasing need for specialized agricultural infrastructure and controlled environment farming solutions.
- Potential for geographic expansion into new domestic and international markets for its specialized products.
What Threats Does BNOW Face?
- Intense competition from larger, more established chemical and bioscience companies.
- Regulatory changes in chemical manufacturing or agricultural practices could impact product viability.
- Economic downturns could reduce demand in hospitality and non-essential agricultural investments.
- Challenges in securing capital for growth and R&D due to small market cap and OTC status.
What Are BNOW's Competitive Advantages?
- Proprietary DiOx+ activated chlorine dioxide formula, offering a potent and environmentally safe disinfectant solution.
- Specialized nano-emulsification technology for liquid nutritional supplements, enhancing product efficacy and stability.
- Diverse product portfolio catering to critical and varied sectors (healthcare, food, agriculture), reducing reliance on a single market.
- Expertise in reconfiguring shipping containers for specialized agricultural applications, addressing a niche market need.
What Does BNOW Do?
Boon Industries, Inc. is a bioscience firm headquartered in Grass Valley, California, dedicated to engineering specialized chemical products for a diverse array of industries. The company's operational scope extends across agriculture, food and beverages, hospitality, and healthcare sectors, addressing both domestic and international markets. At the core of its product portfolio is DiOx+, an activated chlorine dioxide formula recognized for its efficacy as a potent disinfectant and sterilizer. This solution is specifically designed to eradicate harmful pathogens while maintaining safety standards for both human interaction and environmental impact, positioning it as a critical offering in hygiene-sensitive environments. Beyond its flagship disinfectant, Boon Industries diversifies its revenue streams through the manufacturing of bespoke white-label goods. A notable example includes liquid nutritional supplement tinctures developed for the food and beverage industry. These supplements leverage advanced nano-emulsification technology, a proprietary method that ensures the stable suspension of particles, enhancing product quality and bioavailability. This technological capability allows the company to cater to evolving consumer demands for innovative health and wellness products. Furthermore, Boon Industries extends its expertise to the agricultural sector by supplying reconfigured shipping containers. These containers are custom-tailored for various agricultural applications, providing specialized infrastructure solutions that support modern farming practices. The company's strategic focus on distinct, high-value product lines, combined with its commitment to bioscience innovation, underpins its market position. Despite its lean operational structure, with a small team, Boon Industries aims to deliver specialized solutions across critical sectors, emphasizing safety, efficacy, and technological advancement in its product development.
What Products and Services Does BNOW Offer?
- Engineers chemical products for diverse sectors including agriculture, food and beverages, hospitality, and healthcare.
- Manufactures DiOx+, an activated chlorine dioxide formula used as a potent disinfectant and sterilizer.
- Develops solutions that effectively eradicate detrimental pathogens while ensuring safety for individuals and the environment.
- Produces bespoke white-label liquid nutritional supplement tinctures for the food and beverage sector.
- Utilizes nano-emulsification technology in supplements to maintain particle suspension and enhance efficacy.
- Supplies reconfigured shipping containers specifically tailored for various agricultural applications.
How Does BNOW Make Money?
- Sells proprietary chemical disinfectant solutions (DiOx+) directly to businesses in healthcare, hospitality, and food processing.
- Offers white-label manufacturing services for liquid nutritional supplements, leveraging specialized nano-emulsification technology for other brands.
- Provides specialized agricultural infrastructure by reconfiguring shipping containers for specific farming needs.
What Industry Does BNOW Operate In?
Boon Industries, Inc. operates within the Chemicals industry, a segment of the broader Basic Materials sector. This industry is characterized by its foundational role in supplying essential components and solutions to a wide range of downstream sectors, including agriculture, food and beverages, and healthcare—all areas Boon Industries serves. The global chemicals market is influenced by trends such as increasing demand for sustainable and environmentally friendly solutions, advancements in biotechnology, and the need for specialized chemical formulations. Boon Industries positions itself within this landscape by focusing on bioscience-engineered products like activated chlorine dioxide (DiOx+) for disinfection and nano-emulsification technology for nutritional supplements. While the company's specific niche in these advanced chemical applications allows it to address high-value segments, it competes with larger, more established chemical manufacturers that possess greater R&D budgets and distribution networks. The market for disinfectants and specialized food ingredients is robust, driven by health regulations and consumer demand for functional products, offering a fertile ground for companies with innovative solutions.
Who Are BNOW's Key Customers?
- Healthcare facilities and hospitals requiring advanced disinfection and sterilization solutions.
- Food and beverage manufacturers seeking white-label nutritional supplements with advanced delivery systems.
- Hospitality businesses (hotels, restaurants) needing effective and safe cleaning agents.
- Agricultural enterprises and farmers requiring specialized infrastructure solutions like reconfigured shipping containers.
- Companies seeking environmentally conscious and safe pathogen eradication solutions.
Company Profile
Boon Industries, Inc. operates in the Chemicals industry within the Basic Materials sector. It is headquartered in Grass Valley, US. The company is led by CEO William J. Reed.
Boon Industries, Inc. (BNOW) Valuation Context
Relative to its peer group, BNOW's quantitative score of 45/100 is roughly in line with the peer average of 54/100.
ROE 8%Key Financial Metrics
Return on equity for Boon Industries, Inc. stands at 7.7%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -0.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 6/9Financial Health
Boon Industries, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -11.88 places it in the distress zone, a signal of elevated financial risk.
BNOW Financials
Bull Case vs Bear Case
Bull Case
- Diverse product portfolio catering to critical sectors (DiOx+, nutritional supplements, agricultural containers).
- Proprietary DiOx+ formula offers effective and environmentally safe disinfection.
- Utilizes advanced nano-emulsification technology for enhanced nutritional supplement products.
- Strong gross margin of 63.7% indicates efficient product-level cost management.
Bear Case
- Significant negative profit margin (-15535.5%) indicates substantial operational losses.
- Very small employee base (2 employees) may limit scalability and operational capacity.
- OTC Other listing implies less stringent reporting and potential transparency issues.
- High beta (2.44) suggests considerable stock price volatility and increased investment risk.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
BNOW Latest News
No recent news available for BNOW.
BNOW Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BNOW.
Price Targets
Wall Street price target analysis for BNOW.
BNOW MoonshotScore
What does this score mean?
The MoonshotScore rates BNOW's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: William J. Reed
CEO
William J. Reed serves as the CEO of Boon Industries, Inc., leading a lean team of two employees. His background is likely rooted in bioscience, chemical engineering, or a related scientific discipline, given the company's focus on advanced chemical products and nano-emulsification technology. Reed's career trajectory would have involved significant experience in product development, manufacturing processes, and market strategy within specialized chemical or biotechnology sectors. His leadership is crucial in navigating the complexities of developing and commercializing solutions for diverse industries such as agriculture, healthcare, and food and beverages, emphasizing both scientific rigor and market applicability.
Track Record: Under William J. Reed's leadership, Boon Industries, Inc. has developed and brought to market its flagship DiOx+ activated chlorine dioxide formula, establishing a presence in critical disinfection markets. He has also overseen the implementation of nano-emulsification technology for white-label nutritional supplements, demonstrating a commitment to advanced product development. Reed has guided the company in diversifying its offerings to include reconfigured shipping containers for agricultural use, showcasing strategic adaptability in addressing varied industry needs. His management has been instrumental in maintaining operations with a small team while pursuing specialized product lines.
BNOW OTC Market Information
Boon Industries, Inc. (BNOW) trades on the 'OTC Other' tier, which is the lowest and least regulated segment of the OTC market. Unlike companies listed on national exchanges like the NYSE or NASDAQ, or even higher OTC tiers like OTCQB or OTCQX, 'OTC Other' companies face significantly less stringent reporting and disclosure requirements. This tier typically includes companies that do not meet the minimum financial or disclosure standards for other markets, meaning investors have access to less comprehensive and less frequent financial information, which can complicate due diligence and risk assessment.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lack of Transparency: 'Unknown' disclosure status means limited access to financial statements and operational updates, hindering informed investment decisions.
- Low Liquidity: Trading on 'OTC Other' often results in low trading volumes and wide bid-ask spreads, making it difficult to buy or sell shares efficiently.
- Regulatory Oversight: Significantly less stringent regulatory requirements compared to major exchanges, increasing potential for fraud or misleading information.
- Price Volatility and Manipulation: Low liquidity and limited oversight can make the stock susceptible to extreme price fluctuations and potential manipulation.
- Difficulty Raising Capital: The 'OTC Other' status can make it challenging for the company to attract institutional investors or raise capital for growth initiatives.
- Verify any available financial statements directly from the company or regulatory filings, if they exist.
- Research the background and track record of CEO William J. Reed and other key personnel.
- Investigate the market demand and competitive landscape for DiOx+, nano-emulsified supplements, and agricultural containers.
- Assess the company's operational capabilities and manufacturing processes for its specialized products.
- Look for any news, press releases, or independent reports that might provide insight into company performance or compliance.
- Understand the specific risks associated with investing in 'OTC Other' tier stocks, including potential for illiquidity and lack of information.
- Evaluate the company's intellectual property protection for its proprietary formulas and technologies.
- Clearly defined product lines: DiOx+ disinfectant, nano-emulsified supplements, and reconfigured agricultural containers.
- Operations in specific, tangible sectors: agriculture, food and beverages, hospitality, and healthcare.
- Headquartered in a physical location: Grass Valley, California, indicating a tangible operational base.
- Focus on specialized technology: use of nano-emulsification and activated chlorine dioxide suggests a scientific foundation.
BNOW Basic Materials Stock FAQ
What does Boon Industries, Inc. do?
Boon Industries, Inc. is a bioscience firm that engineers and manufactures specialized chemical products for a diverse range of sectors, including agriculture, food and beverages, hospitality, and healthcare. Its core offerings include DiOx+, an activated chlorine dioxide formula that serves as a potent disinfectant and sterilizer, effectively eradicating pathogens while being safe for users and the environment. The company also produces bespoke white-label liquid nutritional supplement tinctures, utilizing advanced nano-emulsification technology for enhanced particle suspension. Additionally, Boon Industries supplies reconfigured shipping containers specifically tailored for various agricultural applications, providing unique infrastructure solutions to the farming sector. Headquartered in Grass Valley, California, the company focuses on delivering innovative and safe chemical solutions to critical industries.
What are the key financial metrics investors watch for BNOW?
For Boon Industries, Inc. (BNOW), investors typically monitor several key financial metrics given its operational profile and market position. The **Gross Margin of 63.7%** is crucial, as it indicates the profitability of its core products before operating expenses, suggesting strong pricing power or efficient production costs for its specialized chemical and bioscience offerings. However, the **Profit Margin of -15535.5%** is a critical metric, highlighting significant operational losses relative to revenue, which demands close scrutiny regarding cost structure and path to profitability. The **Market Capitalization of $0.07 billion** signifies its micro-cap status, implying higher risk and potential for volatility. Furthermore, the **Beta of 2.44** suggests the stock is significantly more volatile than the broader market, indicating higher risk exposure. Given its 'OTC Other' listing and 'Unknown' disclosure status, investors also closely watch for any improvements in transparency or financial reporting consistency.
What are the main risks for BNOW?
Boon Industries, Inc. faces several notable risks that investors may want to evaluate. A primary concern is its **significant negative profit margin of -15535.5%**, indicating substantial operational losses that could threaten long-term financial sustainability if not reversed. As an 'OTC Other' listed stock with an 'Unknown' disclosure status, BNOW carries inherent risks of **limited transparency and low liquidity**. This means investors have restricted access to financial information, and trading the stock can be challenging due to low volumes and wide bid-ask spreads. The company also operates in highly competitive sectors (chemicals, bioscience, agriculture), facing **intense competition** from larger, more established players with greater resources. Furthermore, with only two employees, there's a **reliance on key personnel**, which could pose operational and strategic continuity risks. Lastly, the company's products are subject to **stringent regulatory oversight** in the chemical, food, and healthcare industries, and any non-compliance could lead to severe penalties or operational disruptions.
How does Boon Industries, Inc.'s DiOx+ product differentiate itself in the disinfectant market?
Boon Industries, Inc.'s DiOx+ activated chlorine dioxide formula differentiates itself in the competitive disinfectant market through its dual emphasis on potency and safety. As a potent disinfectant and sterilizer, DiOx+ is specifically engineered to effectively eradicate a wide spectrum of detrimental pathogens, which is critical for sectors like healthcare, hospitality, and food processing where hygiene standards are paramount. Beyond its efficacy, a key differentiator is its commitment to ensuring safety for both individuals and the environment. Many traditional disinfectants can pose risks to human health or the ecosystem, but DiOx+ is formulated to mitigate these concerns. This combination of powerful pathogen elimination with a safer profile positions DiOx+ as a preferred solution for institutions and businesses seeking high-performance disinfection without compromising on safety or environmental responsibility, appealing to a growing market demand for sustainable and responsible chemical solutions.
What are the key factors to evaluate for BNOW?
Boon Industries, Inc. (BNOW) holds an AI score of 45/100 (low). Not financial advice.
How frequently does BNOW data refresh on this page?
BNOW prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven BNOW's recent stock price performance?
Boon Industries, Inc. (BNOW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio catering to critical sectors (DiOx+, nutritional supplements, agricultural containers). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BNOW overvalued or undervalued right now?
Valuing Boon Industries, Inc. (BNOW) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.